Published in Hepatitis Weekly, June 25th, 2001
The drug, called AlkovirTM, is a variant of natural sugars. Its mechanism of action is under investigation, but it appears to work in a different manner than the other hepatitis B drugs in use.
"This means we may have a new pathway of vulnerability to pursue against the disease," said Timothy Block, PhD, Hepatitis B Foundation. "We're extremely encouraged by the prospect of Alkovir emerging as a new weapon against hepatitis B."
The discovery, reported in the June...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.